MAIA Biotechnology raises ~$329K via warrant exercise inducement at reduced $1.50/share

MAIA Biotechnology, Inc.

On June 17, 2025, MAIA entered inducement letters with holders of four warrant series to exercise for cash at reduced exercise price of $1.50 per share.
Total warrants exercised: 219,283 shares; expected gross proceeds of approximately $328,925.
Closing expected on or about June 18, 2025; proceeds for general corporate purposes.
Shares issued as restricted securities exempt under Section 4(a)(2), Rule 506, and/or Section 3(a)(9) of the Securities Act.
Participating holders include Pre-IPO, March 2024, November 2024, and December 2024 warrant holders.

item 1.01item 3.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.